Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS
Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS
Recruiting · NCT07616037 · Registry updated 2026-05-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS | Adnexal Diseases, Cysts, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, endocrine system disorder, female reproductive system disorder, gonadal disorder, neoplasm, ovarian cyst, ovarian disorder, polycystic ovary syndrome | Recruiting | Phase 2 | 2026-05-29 | NCT07616037 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Zhongshan Hospital | 347 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhongshan Hospital, Fudan University | Shanghai | China | 2 |